N.v. Fund - Net Worth and Insider Trading

N.v. Fund Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, N.v. Fund owns 1 companies in total, including Immunic Inc (IMUX) .

Click here to see the complete history of N.v. Fund’s form 4 insider trades.

Insider Ownership Summary of N.v. Fund

Ticker Comapny Transaction Date Type of Owner
IMUX Immunic Inc 2019-04-12 10 percent owner

N.v. Fund Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

N.v. Fund Ownership Network

Ownership Network List of N.v. Fund

No Data

Ownership Network Relation of N.v. Fund

Insider Network Chart

N.v. Fund Owned Company Details

What does Immunic Inc do?

Who are the key executives at Immunic Inc?

N.v. Fund is the 10 percent owner of Immunic Inc. Other key executives at Immunic Inc include director & CEO & President Daniel Vitt , PAO and Controller Glenn Whaley , and Chief Medical Officer Andreas Muehler .

Immunic Inc (IMUX) Insider Trades Summary

Over the past 18 months, N.v. Fund made no insider transaction in Immunic Inc (IMUX). Other recent insider transactions involving Immunic Inc (IMUX) include a net purchase of 14,000 shares made by Daniel Vitt , and a net purchase of 5,000 shares made by Glenn Whaley .

In summary, during the past 3 months, insiders sold 0 shares of Immunic Inc (IMUX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunic Inc (IMUX) were sold and 19,000 shares were bought by its insiders, resulting in a net purchase of 19,000 shares.

Immunic Inc (IMUX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Immunic Inc Insider Transactions

No Available Data

N.v. Fund Mailing Address

Above is the net worth, insider trading, and ownership report for N.v. Fund. You might contact N.v. Fund via mailing address: Groot Begijnhof 60/001, Leuven C9 3000.

Discussions on N.v. Fund

No discussions yet.